WILLIAM K HEIDEN Insider Trading $AVM AMAG PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM K HEIDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM K HEIDEN. WILLIAM K HEIDEN is CEO in AMAG PHARMACEUTICALS INC. ($AVM) and President & CEO in AMAG PHARMACEUTICALS INC. ($AVM) and President and CEO in AMAG PHARMACEUTICALS INC. ($AVM) and President & COO in PRAECIS PHARMACEUTICALS INC ($PRCS) and President and COO in PRAECIS PHARMACEUTICALS INC ($PRCS) and Director in Atara Biotherapeutics, Inc. ($ATRA).
WILLIAM K HEIDEN in AMAG PHARMACEUTICALS, INC.
Trading Symbol: AVMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM K HEIDEN: President & CEO, President and CEO
Holdings: 424,612 shares
Latest Transaction: Mar 04 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of WILLIAM K HEIDEN in AMAG PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, ATRA, PRCS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 7.75 | 4,451 | 34,495 | 424,612 | 429.1 K to 424.6 K (-1.04 %) |
May 09 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Buy | P | 10.70 | 10,000 | 107,000 | 490,056 | 480.1 K to 490.1 K (+2.08 %) |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Option Exercise | A | 15.51 | 70,000 | 1,085,700 | 70,000 | |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 132,000 | 0 | 488,058 | 356.1 K to 488.1 K (+37.07 %) |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 31,000 | 0 | 356,058 | 325.1 K to 356.1 K (+9.54 %) |
Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 15.51 | 2,957 | 45,863 | 325,058 | 328 K to 325.1 K (-0.90 %) |
Aug 08 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Sell | S | 25.00 | 5,000 | 125,000 | 328,015 | 333 K to 328 K (-1.50 %) |
Jun 05 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Sell | S | 25.00 | 20,000 | 500,000 | 333,015 | 353 K to 333 K (-5.67 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Option Exercise | A | 21.00 | 100,000 | 2,100,000 | 100,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 21.00 | 10,546 | 221,466 | 353,015 | 363.6 K to 353 K (-2.90 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 45,500 | 0 | 363,561 | 318.1 K to 363.6 K (+14.31 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 45,500 | 0 | 318,061 | 272.6 K to 318.1 K (+16.69 %) |
May 10 2017 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 18.55 | 19,085 | 354,027 | 272,561 | 291.6 K to 272.6 K (-6.54 %) |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Option Exercise | A | 23.75 | 65,000 | 1,543,750 | 65,000 | |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Grant | A | 0.00 | 55,000 | 0 | 291,646 | 236.6 K to 291.6 K (+23.24 %) |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Grant | A | 0.00 | 30,000 | 0 | 236,646 | 206.6 K to 236.6 K (+14.52 %) |
May 17 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 18.27 | 11,812 | 215,805 | 206,646 | 194.8 K to 206.6 K (+6.06 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Option Exercise | A | 25.18 | 85,000 | 2,140,300 | 85,000 | |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Grant | A | 0.00 | 36,000 | 0 | 218,458 | 182.5 K to 218.5 K (+19.73 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 26.28 | 1,701 | 44,702 | 182,458 | 184.2 K to 182.5 K (-0.92 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 27.01 | 1,843 | 49,779 | 184,159 | 186 K to 184.2 K (-0.99 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 27.01 | 4,070 | 109,931 | 186,002 | 190.1 K to 186 K (-2.14 %) |
Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 27.01 | 10,649 | 287,629 | 190,072 | 200.7 K to 190.1 K (-5.31 %) |
Oct 02 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 39.69 | 2,000 | 79,380 | 200,721 | 202.7 K to 200.7 K (-0.99 %) |
Sep 02 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 61.19 | 2,000 | 122,380 | 202,721 | 204.7 K to 202.7 K (-0.98 %) |
Aug 05 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 64.53 | 2,000 | 129,060 | 204,721 | 206.7 K to 204.7 K (-0.97 %) |
Jul 17 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Option Exercise | M | 12.99 | 20,000 | 259,800 | 210,000 | |
Jul 17 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 75.00 | 20,000 | 1,500,000 | 206,721 | 226.7 K to 206.7 K (-8.82 %) |
Jul 17 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Buy | M | 12.99 | 20,000 | 259,800 | 226,721 | 206.7 K to 226.7 K (+9.67 %) |
Jul 02 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 69.41 | 2,000 | 138,820 | 206,721 | 208.7 K to 206.7 K (-0.96 %) |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Option Exercise | M | 12.99 | 60,000 | 779,400 | 230,000 | |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 71.52 | 12,128 | 867,395 | 208,721 | 220.8 K to 208.7 K (-5.49 %) |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 70.69 | 4,680 | 330,829 | 220,849 | 225.5 K to 220.8 K (-2.08 %) |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 69.77 | 36,550 | 2,550,094 | 225,529 | 262.1 K to 225.5 K (-13.95 %) |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 68.90 | 6,642 | 457,634 | 262,079 | 268.7 K to 262.1 K (-2.47 %) |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Buy | M | 12.99 | 60,000 | 779,400 | 268,721 | 208.7 K to 268.7 K (+28.75 %) |
Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Sell | S | 68.14 | 6,875 | 468,463 | 208,721 | 215.6 K to 208.7 K (-3.19 %) |
Jun 04 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 67.77 | 11,378 | 771,087 | 215,596 | 227 K to 215.6 K (-5.01 %) |
Mar 05 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President and CEO | Payment of Exercise | F | 49.70 | 2,474 | 122,958 | 226,974 | 229.4 K to 227 K (-1.08 %) |
Feb 27 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President and CEO | Option Exercise | A | 49.46 | 60,000 | 2,967,600 | 60,000 | |
Feb 27 2015 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President and CEO | Grant | A | 0.00 | 30,000 | 0 | 229,448 | 199.4 K to 229.4 K (+15.04 %) |
Page: 1